| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
69,344 |
58,616 |
$10.53M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
55,939 |
50,113 |
$7.82M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,994 |
18,193 |
$2.68M |
| 71045 |
Radiologic examination, chest; single view |
19,035 |
16,094 |
$2.57M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
36,147 |
29,702 |
$2.34M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,246 |
2,696 |
$1.31M |
| 93296 |
|
8,758 |
7,169 |
$1.08M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
32,944 |
27,752 |
$1.01M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,957 |
5,461 |
$851K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,086 |
9,947 |
$769K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,182 |
15,458 |
$745K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,805 |
5,164 |
$472K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
82,961 |
66,403 |
$449K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
6,328 |
1,949 |
$415K |
| 71046 |
Radiologic examination, chest; 2 views |
4,541 |
3,961 |
$388K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,786 |
1,211 |
$388K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,150 |
2,581 |
$385K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,063 |
2,831 |
$380K |
| 95806 |
|
666 |
577 |
$376K |
| 99218 |
|
1,224 |
363 |
$361K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,082 |
1,971 |
$331K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,272 |
1,844 |
$313K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,855 |
3,578 |
$299K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,876 |
1,642 |
$294K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
476 |
313 |
$272K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
50,463 |
42,032 |
$267K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,335 |
5,566 |
$264K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,253 |
2,946 |
$261K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,193 |
4,193 |
$250K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,941 |
3,541 |
$210K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
122 |
104 |
$200K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
324 |
258 |
$178K |
| 80053 |
Comprehensive metabolic panel |
22,174 |
16,233 |
$167K |
| 36415 |
Collection of venous blood by venipuncture |
48,507 |
41,143 |
$158K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,471 |
1,381 |
$155K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,348 |
1,123 |
$139K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
890 |
702 |
$126K |
| 62323 |
|
130 |
113 |
$125K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,678 |
2,288 |
$124K |
| 62321 |
|
121 |
91 |
$123K |
| 84484 |
|
15,070 |
10,142 |
$120K |
| 99221 |
|
397 |
133 |
$120K |
| 97162 |
|
1,595 |
1,369 |
$120K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,974 |
1,867 |
$87K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,197 |
814 |
$79K |
| 29580 |
|
1,521 |
566 |
$74K |
| 90834 |
Psychotherapy, 45 minutes with patient |
782 |
599 |
$66K |
| 99215 |
Prolong outpt/office vis |
835 |
631 |
$63K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
625 |
586 |
$62K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,539 |
1,380 |
$60K |
| 81001 |
|
25,318 |
21,699 |
$57K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,325 |
827 |
$57K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,002 |
2,384 |
$54K |
| 80076 |
|
8,810 |
7,447 |
$48K |
| 97161 |
|
571 |
510 |
$48K |
| 83690 |
|
8,548 |
7,152 |
$34K |
| 76604 |
|
322 |
279 |
$33K |
| 97163 |
|
405 |
355 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
62 |
54 |
$29K |
| 93298 |
|
157 |
134 |
$26K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,122 |
1,062 |
$25K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
216 |
140 |
$25K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
43 |
39 |
$24K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
727 |
324 |
$21K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
398 |
306 |
$19K |
| 81025 |
|
3,385 |
2,870 |
$18K |
| 80061 |
Lipid panel |
2,094 |
1,927 |
$17K |
| 64493 |
|
15 |
15 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,545 |
1,381 |
$16K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
48 |
45 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
385 |
320 |
$16K |
| 84703 |
|
2,508 |
2,213 |
$15K |
| 97116 |
|
758 |
305 |
$15K |
| 97166 |
|
104 |
90 |
$13K |
| 83605 |
|
1,734 |
1,375 |
$12K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
60 |
56 |
$11K |
| 90839 |
|
171 |
133 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
138 |
115 |
$9K |
| 80050 |
General health panel |
93 |
89 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
162 |
126 |
$9K |
| 83735 |
|
2,236 |
1,117 |
$9K |
| 83615 |
|
2,160 |
1,123 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
719 |
642 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,303 |
1,105 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
262 |
251 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
261 |
250 |
$7K |
| 82728 |
|
1,013 |
895 |
$7K |
| 87634 |
|
115 |
108 |
$7K |
| 95886 |
|
15 |
15 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
245 |
230 |
$7K |
| 84100 |
|
2,069 |
1,039 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
116 |
80 |
$6K |
| 83970 |
|
382 |
347 |
$6K |
| 77336 |
|
25 |
12 |
$5K |
| 92523 |
|
31 |
26 |
$5K |
| 93225 |
|
19 |
13 |
$5K |
| 87631 |
|
38 |
37 |
$4K |
| 97167 |
|
48 |
36 |
$4K |
| 84702 |
|
391 |
348 |
$4K |
| 83880 |
|
139 |
132 |
$4K |
| 99201 |
|
155 |
132 |
$3K |
| 83540 |
|
744 |
607 |
$3K |
| 87276 |
|
572 |
431 |
$3K |
| 36416 |
|
181 |
157 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
13 |
$3K |
| 84425 |
|
345 |
318 |
$3K |
| 87275 |
|
572 |
431 |
$3K |
| 74246 |
|
12 |
12 |
$3K |
| 87641 |
|
133 |
121 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
303 |
266 |
$2K |
| 96376 |
|
133 |
114 |
$2K |
| 83525 |
|
210 |
195 |
$2K |
| 82607 |
|
349 |
322 |
$2K |
| 84466 |
|
216 |
181 |
$2K |
| 86140 |
|
498 |
437 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
104 |
49 |
$2K |
| 82746 |
|
192 |
174 |
$2K |
| 85379 |
|
228 |
198 |
$2K |
| 86480 |
|
31 |
30 |
$2K |
| 92526 |
|
18 |
13 |
$1K |
| 96040 |
|
15 |
12 |
$1K |
| 36591 |
|
16 |
13 |
$1K |
| 93226 |
|
19 |
13 |
$1K |
| 84134 |
|
352 |
325 |
$956.72 |
| 94761 |
|
114 |
36 |
$918.47 |
| 73562 |
|
17 |
12 |
$842.81 |
| 82077 |
|
76 |
62 |
$841.17 |
| 84460 |
|
233 |
204 |
$837.44 |
| 80074 |
|
16 |
16 |
$776.37 |
| 88173 |
|
40 |
24 |
$767.94 |
| 85652 |
|
405 |
348 |
$751.50 |
| 64494 |
|
24 |
14 |
$692.82 |
| 85027 |
|
148 |
123 |
$687.00 |
| 84439 |
|
132 |
118 |
$677.92 |
| 86803 |
|
53 |
51 |
$662.26 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
38 |
$565.01 |
| 88304 |
|
16 |
15 |
$527.24 |
| 82565 |
|
136 |
116 |
$458.21 |
| 82040 |
|
142 |
123 |
$447.22 |
| 88172 |
|
40 |
24 |
$426.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
16 |
$392.50 |
| 97760 |
|
30 |
24 |
$378.85 |
| 73630 |
|
19 |
12 |
$245.53 |
| 82180 |
|
32 |
26 |
$235.22 |
| 84480 |
|
16 |
16 |
$218.91 |
| 80069 |
|
37 |
27 |
$172.16 |
| 82962 |
|
52 |
44 |
$144.58 |
| 72100 |
|
12 |
12 |
$137.79 |
| 84450 |
|
33 |
28 |
$122.33 |
| 83550 |
|
15 |
12 |
$121.32 |
| 84436 |
|
17 |
17 |
$118.85 |
| 81003 |
|
107 |
82 |
$97.50 |
| 82465 |
|
16 |
16 |
$72.94 |
| 82247 |
|
15 |
12 |
$70.28 |
| 82248 |
|
15 |
12 |
$70.28 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
41 |
24 |
$55.95 |
| 73130 |
|
15 |
12 |
$51.03 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,294 |
9,429 |
$14.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,794 |
1,480 |
$9.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
319 |
265 |
$7.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
630 |
481 |
$0.34 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,055 |
748 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,741 |
865 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
503 |
352 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
280 |
221 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
281 |
228 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
81 |
53 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
48 |
26 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
210 |
151 |
$0.00 |
| C1769 |
Guide wire |
25 |
12 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
19 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,671 |
1,244 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
386 |
237 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
39 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
42 |
38 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
44 |
40 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
18 |
12 |
$0.00 |